Compass Pathways (MEX:CMPSN) PB Ratio: 5.54 (As of Jun. 29, 2026)


MEX:CMPSN Compass Pathways PLC MEX:CMPSN
14 GF Score
Price MXN242.00
! 2 Warning Signs
View Full Analysis

What is Compass Pathways PB Ratio?

Compass Pathways MEX:CMPSN 14 PB Ratio is 5.54 as of Jun. 29, 2026. GuruFocus rates MEX:CMPSN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Compass Pathways ranks worse than 85.2% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), Compass Pathways's share price is MXN242.00. Compass Pathways's Book Value per Share for the quarter that ended in Mar. 2026 was MXN43.66. Hence, Compass Pathways's PB Ratio of today is 5.54.

The historical rank and industry rank for Compass Pathways's PB Ratio or its related term are showing as below:

MEX:CMPSN' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 6.13
Current: 6.13

During the past 8 years, Compass Pathways's highest PB Ratio was 6.13. The lowest was 0.00. And the median was 0.00.

MEX:CMPSN's PB Ratio is ranked worse than
85.2% of 608 companies
in the Healthcare Providers & Services industry
Industry Median: 1.985 vs MEX:CMPSN: 6.13

During the past 12 months, Compass Pathways's average Book Value Per Share Growth Rate was -124.40% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Compass Pathways was -12.70% per year. The lowest was -30.70% per year. And the median was -21.70% per year.

Back to Basics: PB Ratio


Compass Pathways  (MEX:CMPSN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Compass Pathways PB Ratio Related Terms


Compass Pathways PB Ratio Historical Data

* Premium members only.

The historical data trend for Compass Pathways's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compass Pathways PB Ratio Chart

Compass Pathways Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 1.98 0.00

Compass Pathways Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.16 2.84 13.23 0.00 2.21

MEX:CMPSN vs AGL, MD, SEM: PB Ratio Comparison

For the Medical Care Facilities subindustry, Compass Pathways's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Compass Pathways PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's PB Ratio distribution charts can be found below:

* The bar in red indicates where Compass Pathways's PB Ratio falls into.


MEX:CMPSN
14GF Score
Compass Pathways PLC MEX:CMPSN
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compass Pathways PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Compass Pathways's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=242.00/43.662
=5.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 5.54 mean?
Compass Pathways (MEX:CMPSN) has a PB Ratio of 5.54 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Compass Pathways and its competitors. According to the industry distribution chart, Compass Pathways ranks #518 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 85.2%.
Is Compass Pathways' PB Ratio too high?
Compass Pathways' current PB Ratio is 5.54. The Healthcare Providers & Services industry median PB Ratio is 1.99. Compass Pathways' value of 5.54 is 179.1% above this industry median. Based on the distribution chart, Compass Pathways ranks #518 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Compass Pathways has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' PB Ratio compare to AGL and MD?
According to the Healthcare Providers & Services industry distribution chart, Compass Pathways ranks #518 out of 608 companies for PB Ratio. This places Compass Pathways in the lower half of its industry. The industry median PB Ratio is 1.99. Compass Pathways' value of 5.54 is 179.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compass Pathways's current PB Ratio of 5.54 is 179.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Compass Pathways and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compass Pathways's current PB Ratio is 5.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current PB Ratio of 5.54. The current PB Ratio is 5.54 and 179.1% above the Healthcare Providers & Services industry median of 1.99. Compass Pathways' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current PB Ratio is 5.54 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Compass Pathways Business Description

Other Exchanges CMPS:USA5Y6:Germany
Address 33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
14GF Score

Get the complete analysis for MEX:CMPSN

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN242.00
Price